Status:
COMPLETED
Endovascular Treatment for AIS in Chinese Municipal and County Hospitals： A "Real World" Study-ETERNITY Registry
Lead Sponsor:
Wen-huo Chen
Conditions:
Endovascular Treatment
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the Endovascular Treatment difference between Chinese city and country hospital.
Detailed Description
Endovascular Treatment for AIS in Chinese Municipal and County Hospitals： A "Real World" Study-ETERNITY Registry is an academic , independent, pragmatic , prospective , multicenter , observational reg...
Eligibility Criteria
Inclusion
- (1) age ≥18 years; (2) diagnosis of AIS caused by imaging-confirmed intracranial LVO, including isolated cervical internal carotid artery or tandem occlusion, intracranial internal carotid artery, middle cerebral artery (M1/M2), anterior cerebral artery (A1/A2); (3) initiation of any type of EVT, including mechanical thrombectomy, emergent angioplasty via balloon or/and stent; (4).Onset-to-presentation time with 24 hours; (5).Patients whose onset-to-presentation time surpass 6 hours should had CTP and fulfill with DAWN\[6\] or DEFUSE's\[7\] criteria.
Exclusion
- (1) Without follow up outcome; (2) posterior circulation stroke;(3)no evidence of LVO on angiogram.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
1196 Patients enrolled
Trial Details
Trial ID
NCT06078917
Start Date
November 1 2021
End Date
July 31 2023
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhangzhou Municipal Hospital
Zhangzhou, Fujian, China, 363000